Bookmark and Share Print This Page

"Human Gene Editing & Precision Medicine"

Featured Speaker:

Eric Kmiec

Eric Kmiec, Ph.D.
Founder and Director
Gene Editing Institute at the Helen F. Graham Cancer Center, Christiana Care Health System

Malcolm D'Souza Bio

The re-engineering of human chromosomes is taking place at a rapid rate using a recently developed molecular toolbox. Among the most important tools in the box is CRISPR/Cas9, a remarkable gene editing instrument that enables the precise and sometimes imprecise rearrangement of DNA sequences at a frequency once thought to be impossible. In fact, the rapid advancement of these genetic tools have led to an explosion in development of human therapeutics for the treatment of inherited diseases and cancer. As with any quickly expanding discipline, a number of potential pitfalls have begun to emerge.

In this presentation, we will define what is the fact, what is artifact and what is fiction surrounding human gene editing. We will touch upon what is truly feasible in the restructuring of human cells and discuss the ethical and practical challenges that face scientists carrying out CRISPR-directed human genome editing.


Thursday, August 3, 2017
5:30 - 7:30 p.m.


Delaware Biotechnology Institute
15 Innovation Way
Newark, DE 19711


$25 for Delaware Bio Members
$45 for Non-Members

No charge - UD Postdoc/Delaware Biotechnology Institute Resident
(Sponsored by DBI)

No charge - UD INBRE Students/Alumni
(Sponsored by Delaware INBRE)

Registration fee includes:
Hors d'oeuvres & one free beverage.
Cash bar will also be available.

MUST be a scientist, engineer, healthcare professional, postdoc, or attorney with a science background to attend

Register Now

Deadline to Register: Friday, July 28, 2017

For more information:

Ruby Harrington

Series Sponsors: